Principal Investigator: Dr. Natasha Slesnick
Co P.I.'s: Dr. Robert J. Meyers, Dr. J. Scott Tonigan, and Dr. William R. Miller
Dr. Slesnick and her team of colleagues at UNM CASAA are conducting the TORA II project. TORA II is funded by NIDA and is in its first year of study. TORA II is a Stage 2 clinical trial that builds on the TORA project, which was a Stage 1 FIRST award trial. TORA II examines outcome for three theoretically distinct interventions that have empirical bases: Community Reinforcement Approach, Motivational Interviewing and Ecologically Based Family Therapy. Participants are recruited from Albuquerque's runaway youth shelters, screened for eligibility, and engaged into the project. The relative effectiveness and therapeutic change process of the proposed interventions for runaway youth will be evaluated at 3, 6, 9, 12, 18 and 24 months after treatment, and will include measures of substance use, family relations, and adolescent functioning. Study aims also will investigate how, if at all, treatment compliance and satisfaction mediate youth response to the three treatments. This project will also evaluate the cost-savings potential associated with each treatment intervention. To our knowledge, this is the first systematic evaluation of a substance use and mental health treatment with this population.
Co P.I.'s: Dr. Robert J. Meyers, Dr. J. Scott Tonigan, and Dr. William R. Miller
Dr. Slesnick and her team of colleagues at UNM CASAA are conducting the TORA II project. TORA II is funded by NIDA and is in its first year of study. TORA II is a Stage 2 clinical trial that builds on the TORA project, which was a Stage 1 FIRST award trial. TORA II examines outcome for three theoretically distinct interventions that have empirical bases: Community Reinforcement Approach, Motivational Interviewing and Ecologically Based Family Therapy. Participants are recruited from Albuquerque's runaway youth shelters, screened for eligibility, and engaged into the project. The relative effectiveness and therapeutic change process of the proposed interventions for runaway youth will be evaluated at 3, 6, 9, 12, 18 and 24 months after treatment, and will include measures of substance use, family relations, and adolescent functioning. Study aims also will investigate how, if at all, treatment compliance and satisfaction mediate youth response to the three treatments. This project will also evaluate the cost-savings potential associated with each treatment intervention. To our knowledge, this is the first systematic evaluation of a substance use and mental health treatment with this population.
